by:
atascabob 1OP
~ 7 years ago
Jan 19, '17 5:16pm
EpiPen gets a new rival- $2,250 a dose
Seriuosly this is what's wrong with the whole system- It's Obama's fault, not really.
The talking auto-injector competitor to Mylan's billion-dollar allergy attack remedy, the Auvi-Q, will return to market Feb. 14, manufacturer Kaleo said Thursday. The price? A whopping $4,500 for two auto-injectors.
And what talking does it do? Does it ask are you broke yet?
I'm not sure on that, do you know that for a fact?
Medical costs are ridiculous, Pharma blames middlemen, Doctors and hospitals blame ins. companies, it's completely out of control. The only winners are corporate executives and shareholders.